“Recommends buying Aurobindo Pharma Futures in the ₹1,650-1,660 range, targeting ₹1,740-1,780, with a stop loss below ₹1,600. This bullish view is driven by the stock breaking its all-time high levels, accompanied by an increase in open interest, indicating a strong long build-up.”

Jay Thakkar’s track record: 5 graded calls · 95% CI 12–77%